FDA Inspection 659160 — Irenda Corporation

Irenda Corporation — FEI 2050154

The FDA completed an inspection of Irenda Corporation on April 29, 2010 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 29, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
194221 CFR 211.180(e)Records reviewed annually
355321 CFR 211.48(a)Plumbing System Defects
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
413221 CFR 589.2000(d)(1)Protein blenders, feed manufacturers, distributors
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs